Rho to Offer Tips to Avoid Trial Failure at MAGI Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Chapel Hill, NC – October 24, 2013 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today they will be presenting tips to avoid trial failure during the MAGI Conference in Las Vegas from October 27-30. This conference provides clinical research professionals with workshops and training sessions in specific tracks such as budgets and billing, contracts, quality, regulatory compliance, site operations, sponsor operations and special topics.

Tara Gladwell, Rho’s vice president of operations, will be presenting the top operational reasons clinical trials fail. She will offer tips that can be implemented before and during a trial to remedy those reasons that can cause trial failure. Information will be provided regarding working with sites, conducting feasibility assessments, and tackling patient enrollment and retention issues.

More reasons and recommended solutions to why clinical trials may fail will be provided during the MAGI conference on Monday, October 28 at 11:30 a.m. PST.

To learn more about Rho, please visit www.rhoworld.com.

About Rho

Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 25 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC